OncoSil Medical LtdASX: OSL

Specialised Therapeutics Australia supporting OncoSil study

· Issued by OncoSil Medical Ltd

Filed with ASX · · 3 pages · English

• Independent pharmaceutical company Specialised Therapeutics Australia (STA) to support Oncosil Medical global Pancreatic Cancer study • STA to supply subsidised ABRAXANE(nanoparticle albumin-bound paclitaxel) to Australian sites for clinical study • ABRAXANEis marketed in Australia by STA under license from Celgene Corporation • Majority of patients recruited at five key Australian trial sites

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases